Koike K - Search Results

1

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma.

Shibata C, Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Koike K. Shibata C, et al. Among authors: koike k. Mol Cell Ther. 2013 Dec 13;1:5. doi: 10.1186/2052-8426-1-5. eCollection 2013. Mol Cell Ther. 2013. PMID: 26056570 Free PMC article. Review.

2

MicroRNAs and liver function.

Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Ohno M, Koike K. Takata A, et al. Among authors: koike k. Minerva Gastroenterol Dietol. 2013 Jun;59(2):187-203. Minerva Gastroenterol Dietol. 2013. PMID: 23831909 Review.

3

MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.

Takata A, Otsuka M, Kojima K, Yoshikawa T, Kishikawa T, Yoshida H, Koike K. Takata A, et al. Among authors: koike k. Biochem Biophys Res Commun. 2011 Aug 12;411(4):826-31. doi: 10.1016/j.bbrc.2011.07.048. Epub 2011 Jul 21. Biochem Biophys Res Commun. 2011. PMID: 21798241

4

Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma.

Otsuka M, Takata A, Yoshikawa T, Kojima K, Kishikawa T, Shibata C, Takekawa M, Yoshida H, Omata M, Koike K. Otsuka M, et al. Among authors: koike k. PLoS One. 2011;6(9):e24359. doi: 10.1371/journal.pone.0024359. Epub 2011 Sep 15. PLoS One. 2011. PMID: 21935400 Free PMC article.

5

A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function.

Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Kudo Y, Goto T, Yoshida H, Koike K. Takata A, et al. Among authors: koike k. Biochem Biophys Res Commun. 2012 Apr 13;420(3):564-9. doi: 10.1016/j.bbrc.2012.03.034. Epub 2012 Mar 16. Biochem Biophys Res Commun. 2012. PMID: 22445758

6

MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.

Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Hikiba Y, Obi S, Goto T, Kang YJ, Maeda S, Yoshida H, Omata M, Asahara H, Koike K. Takata A, et al. Among authors: koike k. Hepatology. 2013 Jan;57(1):162-70. doi: 10.1002/hep.26011. Hepatology. 2013. PMID: 22898998 Free PMC article.

7

Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation.

Yoshikawa T, Takata A, Otsuka M, Kishikawa T, Kojima K, Yoshida H, Koike K. Yoshikawa T, et al. Among authors: koike k. Sci Rep. 2012;2:637. doi: 10.1038/srep00637. Epub 2012 Sep 6. Sci Rep. 2012. PMID: 22957141 Free PMC article.

8

Inhibition of microRNA122 decreases SREBP1 expression by modulating suppressor of cytokine signaling 3 expression.

Shibata C, Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Yoshida H, Koike K. Shibata C, et al. Among authors: koike k. Biochem Biophys Res Commun. 2013 Aug 16;438(1):230-5. doi: 10.1016/j.bbrc.2013.07.064. Epub 2013 Jul 24. Biochem Biophys Res Commun. 2013. PMID: 23891753

9

The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice.

Ohno M, Shibata C, Kishikawa T, Yoshikawa T, Takata A, Kojima K, Akanuma M, Kang YJ, Yoshida H, Otsuka M, Koike K. Ohno M, et al. Among authors: koike k. Sci Rep. 2013;3:2553. doi: 10.1038/srep02553. Sci Rep. 2013. PMID: 23989853 Free PMC article.

10

Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model.

Yoshikawa T, Otsuka M, Kishikawa T, Takata A, Ohno M, Shibata C, Kang YJ, Yoshida H, Koike K. Yoshikawa T, et al. Among authors: koike k. PLoS One. 2013 Sep 2;8(9):e71969. doi: 10.1371/journal.pone.0071969. eCollection 2013. PLoS One. 2013. PMID: 24023722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,103 results

Search Page